The place of DTP/eIPV vaccine in routine pediatric vaccination

Vidor, Emmanuel; Caudrelier, Pierre; Plotkin, Stanley А.

doi:10.1002/rmv.1980040405

Cited by 18 publications

(4 citation statements)

References 77 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At 37ºC there is a significant loss of potency of the type 1 component after 1-2 days and of types 2 and 3 after 2 weeks (120,143). Freezing diminishes potency of IPV, related to loss of the D-antigen structure (143).…”

Section: Inactivated Poliomyelitis Vaccinementioning

confidence: 99%

Effect of Freezing on Oxytocin Ampules

2013

View full text Add to dashboard Cite

Section: Inactivated Poliomyelitis Vaccinementioning

confidence: 99%

Effect of Freezing on Oxytocin Ampules

2013

View full text Add to dashboard Cite

“…IgA induced in the gut plays an important role in terminating primary infection in the intestinal tract and the tonsils [4,203] affecting both fecal-oral and oral-oral transmission. In practice, IPV also induce some intestinal immunity although less than OPV, and the duration of excretion in individuals immunized with IPV appears to be longer [24,94,[207][208][209].…”

Section: Poliovirus Infections At the Level Of The Individual Hostmentioning

confidence: 99%

“…The original IPV formulation has since been improved. This enhanced IPV, eIPV, has a higher immunogenicity and protective efficacy than IPV [208]. A number of factors contributed to this improvement.…”

Section: Poliovirus Infections At the Level Of The Individual Hostmentioning

confidence: 99%

“…It can be administered alone or can be combined with other vaccines such as DTP. The immunogenicity of eIPV was at least as good as that of OPV, and there was good long-term immunity [208]. Subdermal administration of fractional doses of IPV was one of the approaches tried in the early 1950s [17].…”

Section: Poliovirus Infections At the Level Of The Individual Hostmentioning

confidence: 99%

See 1 more Smart Citation

Polio and Its Epidemiology

Shulman¹

2020

Encyclopedia of Sustainability Science and Technology

View full text Add to dashboard Cite

AFP Acute flaccid paralysis. AFP surveillance Characterization of enteroviruses in stool samples from all AFP cases especially in individuals under 15 years of age to rule in or rule out etiology by polioviruses. AFR or AFRO The African Health Region of the WHO. AGG A PID with agammaglobulinemia. AMR or AMRO The American Health Region of the WHO. aVDPV A vaccine-derived poliovirus isolate whose evolutionary path is unknown or ambiguous. bOPV Bivalent oral polio vaccine (containing serotypes 1 and 3). BSL Biosafety standard level. CAG Containment Advisory Group. C-antigens Refers to the epitopes after poliovirus interacts with CD155 host cell receptor and transitions into a 135S particle. Capsid The protein shell that surrounds a virus particle. Capsomere One of the individual morphological units that makes up the viral capsid. It contains a single copy of viral capsid proteins VP1, VP| 2, VP3, and VP4. CAV Coxsackie A virus. CCID 50 The cell culture infectious dose of a virus that will cause cell death in 50% of replicate cell cultures. CDC US Centers for Disease Control and Prevention. CD155 or PVr The human encoded cell receptor for poliovirus, a member of the immunoglobulin superfamily. cDNA Complimentary DNA (DNA synthesized from RNA by a reverse transcriptase enzyme). CNS Central nervous system. Codon A sequence of three adjacent nucleotides on a strand of DNA or RNA that specifies which specific amino acid will be incorporated into a protein. Codon bias Unequal usage of synonymous codons (different codons that specify the same amino acid). CPE Cytopathic effect. CRE Cis-acting replication element. CVID Common variable immune deficiencya type of primary immune deficiency cVDPV A circulating vaccine-derived poliovirus, that is, a poliovirus that has evolved from vaccine during person-to-person transmission. D-antigens Refers to epitopes on native 150S virions. Lester M. Shulman has retired.

show abstract

Developed countries should use inactivated polio vaccine for the prevention of poliomyelitis

Plotkin

1997

Rev. Med. Virol.

View full text Add to dashboard Cite

The place of DTP/eIPV vaccine in routine pediatric vaccination

Cited by 18 publications

References 77 publications

Effect of Freezing on Oxytocin Ampules

Effect of Freezing on Oxytocin Ampules

Polio and Its Epidemiology

Developed countries should use inactivated polio vaccine for the prevention of poliomyelitis

Contact Info

Product

Resources

About